Δ1-pyrroline-5-carboxylate (P5C) reductase 1 (PYCR1) catalyzes the NAD(P)H-dependent conversion of L-P5C to L-proline and is one of the most consistently up-regulated metabolic enzymes in cancer cells. High PYCR1 expression is associated with adverse clinical outcomes, and its knockdown inhibits tumor proliferation and metastasis, motivating inhibitor discovery. All structurally validated PYCR1 inhibitors to date bind in the active site and are anchored in the L-P5C binding pocket by an anionic functional group, typically carboxylate. Seeking inhibitors with alternative anchors, we used X-ray crystallography to screen 22 fragment-like compounds (MW = 189–343 Da) from docking that represent six different carboxylic acid isosteres. Surprisingly, only one compound bound in the active site. Four other compounds were found in three adjacent remote sites located in oligomer interfaces. The compounds bind 7 Å from NADH and 10–14 Å from L-P5C, and the intervening space is blocked by protein for inhibitors in Sites 1A/1B and open for inhibitors in Site 2. Together, the three binding sites define a ligand binding hot spot groove that spans 33 Å. The remote binders inhibit PYCR1 activity with K values from the mixed model of inhibition of 32 μM to 2 mM. Co-crystal structures of PYCR1 with combinations of allosteric inhibitors, NADH, and L-P5C/proline analogs suggest the inhibitors can bind to the ternary PYCR1–L-P5C–NAD(P)H complex in addition to the free enzyme, consistent with a mixed mechanism of inhibition. The discovery of an allosteric inhibitor binding groove that accommodates multiple fragments heralds a new era of PYCR1 inhibitor design.
This study presents the generation of synthetically tractable N-acyl sulfonamide chemical space using a two-step parallel synthetic methodology, providing structurally diverse compounds with high efficiency. The key reaction included the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) combined with primary sulfonamide N-acylation, which proved to be highly effective in generating structurally diverse N-acyl sulfonamides with typically good synthesis success rates (up to 85%) and average yields (up to 61%). The approach demonstrated reliability across different substrates, supporting the efficient construction of a 256-member compound library (out of 73,331 possible combinations) with minor synthetic limitations. Biological evaluations of the synthesized library identified promising inhibitors of human carbonic anhydrase isoforms hCA-IX and hCA-II. Differential scanning fluorimetry and enzymatic assay revealed potent and selective compounds, with some derivatives exhibiting low micromolar IC50 values and noticeable selectivity toward hCA-II. Docking and molecular dynamics simulations provided further insights into binding interactions, confirming the stability of ligand-protein complexes. Thus, this work highlights the synthetic efficiency and pharmacological relevance of 1,2,3-triazole-containing N-acyl sulfonamides, expanding the accessible chemical space for drug discovery.
A synthetically accessible library of N-acyl sulfonamides was constructed using a combination of copper(I)-catalyzed azide–alkyne cycloaddition (CuAAC) and N-acylation of primary sulfonamides. The proposed two-step reaction sequence had a high experimentally confirmed synthetic success rate (up to 85%) and gave reasonable product yields (up to 61%). As a result of the validation process, a 262-member compound library (out of >70K accessible combinations) was prepared. Biological profiling of the synthesized library by differential scanning fluorimetry and enzymatic assays identified several low micromolar inhibitors of human carbonic anhydrase. The interaction of the discovered hits with the biological target was studied by docking and molecular dynamics.
N-Acyl sulfonamides are widely recognized carboxylic acid isosteres that can fill the gap related to acidic compounds in chemical catalogs and bioactivity studies. This study presents the generation of synthetically tractable N-acyl sulfonamide chemical space based on the two-step parallel synthetic methodologies yielding structurally diverse compounds with high efficiency. Amide formation and SNAr combined with primary sulfonamide acylation proved to be highly effective in generating structurally diverse N-acyl sulfonamides with typically good synthesis success rates (up to 83%) and average yields (up to 57%). The approach demonstrated reliability across different substrates, supporting the efficient construction of a 526-member compound library (out of 3,258,356 possible combinations) with minor synthetic limitations. Biological evaluations of the synthesized library identified promising inhibitors of human carbonic anhydrase isoforms hCA-IX and hCA-II. Differential scanning fluorimetry screening and enzymatic assays revealed potent and selective compounds, with some derivatives exhibiting low micromolar IC50 values and selectivity towards either hCA-IX or hCA-II. Molecular docking and molecular dynamics simulations provided further insights into binding interactions, confirming the stability of ligand-protein complexes. Thus, this work highlights the synthetic efficiency and pharmacological relevance of N-acyl sulfonamides, expanding the accessible chemical space for drug discovery.